Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for Healthcare Global Cannabis Leader Poised for Read More
December 21, 2025
The executive order reclassifies marijuana as a Schedule III drug, easing the path for more research. President Donald Trump is Read More
President Donald Trump signed an executive order Thursday reclassifying marijuana as a less dangerous drug a move expected to ease Read More
President Donald Trump signed an executive order Thursday directing federal agencies to reclassify marijuana, loosening long-standing restrictions on the drug Read More
The order to place cannabis in the same category as Tylenol with codeine would mark the most significant change in Read More
Tilray and Canopy Growth shares were among big gainers Thursday. This story appeared on marketwatch.com, 2025-12-18 14:40:00.Read More
LONDON, Dec. 18, 2025 (GLOBE NEWSWIRE) — Crucial Innovations Corp. (CINV or the Company), an international pioneering medical cannabis company, announced that it Read More
Cannabis companies experienced a remarkable Thursday as investors responded enthusiastically to reports that President Donald Trump plans to sign an Read More
Shares of cannabis firms rose in premarket trading on Thursday, driven by expectations that U.S. President Donald Trump will Read More
DOWNEY, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Blum Holdings, Inc. (OTCQB: BLMH) (the Company, Blüm, Blüm Holdings, we or us), Read More